Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

AECL and MDS Nordion enter into 40-year multibillion dollar supply agreement for medical isotopes

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Confidential Client

On February 22, 2006, MDS Inc. announced the conclusion of a comprehensive mediation process with Atomic Energy of Canada Limited (AECL) related to the construction, commissioning and operation of the MAPLE reactors and associated New Processing Facility in Chalk River, Ontario and the long term secure supply of radioisotopes. MDS Nordion is the largest supplier of radioisotopes used in cancer treatment worldwide. The raw material for radioisotopes is produced by AECL in its general purpose nuclear reactor, NRU. This technology and business is one of Canada's high tech medical success stories. The mediation involved John Campion and Paul Monahan (litigation) of Fasken Martineau for MDS Nordion. The agreement was negotiated for MDS Nordion under the direction of Peter Brent, Vice-President, Legal and Corporate Secretary of MDS Inc. with the support of a team from Fasken Martineau comprised of Scott Conover and Doug Scott (corporate), Lisa Abe and Jason Kee (technology outsourcing), Alan Schwartz and David Robertson (tax), and Jon Holmstrom (structuring).

Team

    Subscribe

    Receive email updates from our team

    Subscribe